J B Chemicals & Pharmaceuticals : ESOP/ESPS/SBEB Scheme
August 20, 2022 at 12:36 pm EDT
Share
August 20, 2022
National Stock Exchange of India Limited
Exchange Plaza, 5th Floor, Plot No. C/1,
G-Block, Bandra Kurla Complex,
Bandra (E), Mumbai - 400051.
Stock Symbol: JBCHEPHARM
Dear Sir,
Sub: Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Regulations and Disclosure Requirements) Regulations, 2015 read with the Securities and Exchange Board of India circular bearing reference no. CIR/CFD/CMD/4/2015 dated September 9, 2015
Sub: Allotment of Equity Shares on exercise of Stock options pursuant to Employee Stock Option Scheme
This is to inform you that the Compensation Committee of the Board of Directors of the Company has, on August 20, 2022, allotted 48,130 fully paid up equity shares of Rs. 2/- each of the Company, to certain employees on exercise of stock options granted to them pursuant to JBCPL Employee Stock Option Scheme, 2021.
The issued, subscribed and paid up capital has thus gone up from 7,72,82,097 equity shares of Rs. 2 each to 7,73,30,227 equity shares of Rs. 2 each.
JB Chemicals & Pharmaceuticals Ltd. published this content on 20 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 August 2022 16:35:02 UTC.
J. B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). Its therapeutic categories include gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives and pharmacovigilance. The Company's lozenges products include center-filled, soft-centered lozenges; center-filled, powder lozenges; herbal lozenges, and medicated lozenges. The Company offers a complete range of contrast media products including X-ray, MRI, and ultrasound in India as well as internationally. The Company produces a wide range of dosage forms, such as tablets, capsules, liquids, IV infusions, ampoules, vials, ointments, cold rubs, lozenges and sips. Its brands include Rantac OD, RD, Ranraft, Metrogyl ER, Metrogyl O, Nicardia XL, Sporlac EVA and Sporlac G, among others.